SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-064926
Filing Date
2023-08-09
Accepted
2023-08-09 14:14:31
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_biomxinc.htm   iXBRL 10-Q 521475
2 CERTIFICATION f10q0623ex31-1_biomxinc.htm EX-31.1 9967
3 CERTIFICATION f10q0623ex31-2_biomxinc.htm EX-31.2 10233
4 CERTIFICATION f10q0623ex32_biomxinc.htm EX-32 5907
  Complete submission text file 0001213900-23-064926.txt   3644704

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20230630.xsd EX-101.SCH 50138
6 XBRL CALCULATION FILE phge-20230630_cal.xml EX-101.CAL 31099
7 XBRL DEFINITION FILE phge-20230630_def.xml EX-101.DEF 191165
8 XBRL LABEL FILE phge-20230630_lab.xml EX-101.LAB 416261
9 XBRL PRESENTATION FILE phge-20230630_pre.xml EX-101.PRE 205009
48 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_biomxinc_htm.xml XML 323206
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 231154562
SIC: 2836 Biological Products, (No Diagnostic Substances)